Guidance on regulatory requirements in the context of the COVID-19 pandemic

The European Commission, EMA and the European medicines regulatory network have developed a question-and-answer (Q&A) document to provide guidance to stakeholders on adaptations to the regulatory framework to address challenges arising from the COVID-19 pandemic, with a particular focus on crucial medicines for use in COVID-19 patients.

source https://www.pharmatutor.org/pharma-news/2020/guidance-on-regulatory-requirements-in-the-context-of-the-covid-19-pandemic